UnitedHealth Group Incorporated (UNH)
Can UnitedHealth Group rebound after Berkshire Hathaway's exit?
Shares of UnitedHealth Group fell over 2% on Monday after Berkshire Hathaway disclosed that it had exited its entire position in the health insurer during the first quarter, ending a brief but closely watched investment. The healthcare giant's stock had recently staged a strong rebound, posting its seventh consecutive weekly gain after rising about 4% last week.
Warren Buffett's Berkshire Big Shakeup Continues: UnitedHealth Stake Completely Sold
For years, investors treated Warren Buffett's Berkshire Hathaway ( NYSE:BRK-A | BRK-A Price Prediction )( NYSE:BRK-B ) as the market's ultimate “follow-the-smart-money” signal.
UnitedHealth Group Incorporated (UNH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
UnitedHealth Group Incorporated (UNH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
UnitedHealth: TrumpRx Is A Nothingburger
UnitedHealth Group is rated a slim Buy following a 59% recovery from March lows, driven by strong Q1 results and a favorable 2027 CMS rate decision. Q1 revenue reached $111.72B with EPS of $7.23, prompting management to raise full-year EPS guidance to over $18.25 and authorize a $2B+ Q2 buyback. UNH's vertical integration justifies its premium valuation, but DOJ antitrust risks and PBM regulatory changes could challenge its integrated business model.
Forget UnitedHealth: Two Stocks To Buy Now
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) is back in every headline, riding a 31.24% one-month bounce off a 9.38% Q1 EPS beat that had Reddit cheering a “UnitedHealth +7% premarket” rally on April 21.
UnitedHealth: Beaten Down, Not Broken
UnitedHealth Group Incorporated has surged 18% since my last update, outperforming the benchmark and reinforcing my Strong Buy rating. Despite the recent rally, I still view UNH as undervalued and well-positioned to outperform over the long term. Recent solid double-beat earnings have reignited bullish momentum and improved investor confidence in UNH's consistency.
Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It?
Roughly a year ago, 24/7 Wall St. ran a piece titled Forget UnitedHealth.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
UnitedHealth: Watch The Recovery In Action
UnitedHealth Group is executing a robust turnaround, with Q1 2026 revenue up 2% to $111.7 billion and EPS beating consensus at $7.23. UNH's aggressive repricing, AI-driven efficiencies, and strategic exits support raised 2026 EPS guidance to at least $18.25, with double-digit growth expected through 2028. Shares trade at a forward PE of 19.3, below the 10-year average, implying a 6% discount to a $369 fair value and potential double-digit annualized returns.
UnitedHealth to remove annoying barrier for slew of medical procedures
UnitedHealth said Tuesday it is planning to slash required authorizations by nearly a third later this year – making it easier for patients to access an array of tests, surgeries and procedures.
